Before the Bell Scans: Theravance Inc., Alkermes PLC, Celsion Corp., and
Editor Note: For more information about this release, please scroll to bottom
LONDON, November 14, 2013
LONDON, November 14, 2013 /PRNewswire/ --
The U.S. equity market edged higher on Wednesday, November 13, 2013, with the
S&P 500, the Dow Jones Industrial Average, and the NASDAQ Composite rising
0.81%, 0.45%, and 1.16%, respectively. Shares in the healthcare sector mostly
ended on a higher note, as the broader market edged higher. The major movers
in the sector included Theravance Inc. (NASDAQ: THRX), Alkermes PLC (NASDAQ:
ALKS), Celsion Corporation (NASDAQ: CLSN), and Hospira Inc. (NYSE: HSP). All
these companies are tracked by AAAResearchReports.com. Free technical research
on THRX, ALKS, CLSN, and HSP can be downloaded upon signing up at:
Theravance Inc.'s shares fluctuated between $33.84 and $35.43 before ending
the day 2.30% higher at $35.19. A total of 0.64 million shares were traded,
which is below the daily average volume of 0.84 million. The company's shares
have gained 1.65% in the previous three trading sessions, outperforming the
S&P 500, which has advanced 0.64% during the respective period. Further,
Theravance Inc.'s stock is trading above its 200-day moving average of $33.22.
Sign up today to read free research report on THRX at:
Alkermes PLC's stock advanced on Wednesday, hitting a new 52-week high of
$37.58. The company's shares closed the day at $37.55, up 0.86% from the
previous day's price of $37.23. A total of 0.44 million shares were traded,
which is below the daily average volume of 0.82 million. The company's shares
have gained 18.87% in the last one month and 11.79% in the previous three
months, outperforming the S&P 500, which has advanced 4.63% and 5.18% during
the respective periods. Moreover, Alkermes PLC.'s stock is trading above its
50-day and 200-day moving averages of $34.15 and $29.55, respectively.
Register to download free technical analysis on ALKS at:
Shares in Celsion Corp. fluctuated between $3.78 and $3.93 before ending the
Wednesday's session 1.03% lower at $3.85. A total of 0.21 million shares were
traded, which is below the daily average volume of 0.39 million. The company's
shares have fallen by 3.39% in the previous three trading sessions,
underperforming the S&P 500, which has gained 0.64% during the same period.
Furthermore, Celsion Corp.'s stock is trading below its 50-day and 200-day
moving averages of $5.16 and $5.33, respectively. A free report on CLSN can be
accessed by registering at:
On Wednesday, Hospira Inc.'s stock advanced to close the day at $39.33, up
1.52% from the previous day's closing price of $38.74. The company's shares
vacillated between $38.25 and $39.37 during the trading session. A total of
1.10 million shares were traded, which is above the daily average volume of
0.76 million. The company's shares have gained 1.13% in the previous three
trading sessions, outperforming the S&P 500, which has advanced 0.64% during
the same period. Additionally, Hospira Inc.'s stock is trading above its
200-day moving average of $36.31. Register with AAA Research Reports and
download the research on HSP for free at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Phone #: + 1 (646) 396-9126 Contact Name: Peter F. Jones Email ID:
Press spacebar to pause and continue. Press esc to stop.